entertainment -WSS

entertainment

author：leisure time 2025-08-26 10:52:26 - browse：438

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Duchenne breakthrough therapy leaves behind pioneering families

WSS

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medical records are filled with copy

Alkermes shareholders re

Malaria cases in Florida and Texas: Here’s what you need to know

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

leisure time

entertainment

leisure time

Continuity nursing helped my family in our darkest PICU moments

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Medicare proposal to cover medical devices draws a mixed reaction

10 states plan to sue EPA over standards for residential wood

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Psychedelics group wrestles with new pharma identity

BioMarin wins approval for gene therapy to treat hemophilia A

Sports medicine is finally prioritizing gender equality

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

hotspot

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Hepatitis C has a cure — but many Americans still lack access to it

At least 13 dead in Texas as scorching temps continue

Trump pressured former Arizona governor to overturn 2020 election results: Sources

As demand for Covid shots wanes, Moderna seeks its next success

The cancer drug shortage isn’t new — and neither are the solutions

hotspot

knowledge

explore

leisure time